This month's top tech news stories
Glyconics
Fingernail Scanning
A pioneering scanning device can instantly reveal an individual’s risk of type 2 diabetes through a non-invasive fingernail reading, according to the results of two new studies published at the American Diabetes Association annual meeting. The Glyconics-DS TM device – similar in size to a mobile phone – offers an instant needle-free alternative to the traditional diabetes blood test. Affordable, portable and environmentally sustainable, it enables large-scale screenings for diabetes in any location.
FUJIFILM Irvine Scientific
IVF Clinical Decision making
FUJIFILM Irvine Scientific has announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package, which was launched in 2021. It enables non-invasive evaluation of embryo genetic integrity during in-vitro fertilization (IVF). Life Whisperer Genetics used in conjunction with Life Whisperer Viability uniquely aids in the clinical selection of blastocysts that may have a greater likelihood of being euploid and resulting in pregnancy using a single platform.
MinervaX ApS
Group B Streptococcus
MinervaX ApS, a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), has announced the completion of enrolment and initial dosing in its Phase 1, clinical vaccine trial in older adults. MinervaX has expanded the development pipeline of its novel GBS vaccine to include older adults, addressing the global burden and urgent need for the development of a vaccine to prevent and reduce deaths associated with GBS across the population. MinervaX is currently progressing two Phase II clinical vaccine trials for the prevention of life-threatening infections in newborns.
